Positive feedback regulation of lncRNA TPT1‐AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer

Emerging evidence has indicated that long noncoding RNAs (lncRNAs) are potential biomarkers and play crucial roles in cancer development. However, the functions and underlying mechanisms of lncRNA TPT1‐AS1 in pancreatic ductal adenocarcinoma (PDAC) remain elusive. RNAseq data of PDAC tissues and normal tissues were analyzed, and lncRNAs which were associated with PDAC prognosis were identified. The clinical relevance of TPT1‐AS1 for PDAC patients was explored, and the effects of TPT1‐AS1 in PDAC progression were investigated in vitro and in vivo. LncRNA TPT1‐AS1 was highly expressed in PDAC, and high TPT1‐AS1 levels predicted a poor prognosis. Moreover, functional experiments revealed that TPT1‐AS1 promoted pancreatic cancer cell proliferation, migration, invasion, and epithelial‐to‐mesenchymal transition (EMT) process in vitro and in vivo. Mechanistically, TPT1‐AS1 functioned as an endogenous sponge for miR‐30a‐5p, which increased integrin β3 (ITGB3) level in pancreatic cancer cells. Conversely, our data revealed that ITGB3 could activate the transcription factor signal transducer and activator of transcription 3 (STAT3), which in turn bound directly to the TPT1‐AS1 promoter and affected the expression of TPT1‐AS1, thus forming a positive feedback loop with TPT1‐AS1. Taken together, our results uncovered a reciprocal loop of TPT1‐AS1 and ITGB3 which contributed to pancreatic cancer growth and development, and indicated that TPT1‐AS1 might serve as a novel potential diagnostic biomarker and therapeutic target for PDAC patients.

[1]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[2]  Lixia Xu,et al.  Long noncoding RNA KB-1460A1.5 inhibits glioma tumorigenesis via miR-130a-3p/TSC1/mTOR/YY1 feedback loop. , 2021, Cancer letters.

[3]  Yong Teng,et al.  SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3 , 2021, Journal of experimental & clinical cancer research : CR.

[4]  Ping Huang,et al.  Long non-coding RNA TPT1-AS1 sensitizes breast cancer cell to paclitaxel and inhibits cell proliferation by miR-3156-5p/caspase 2 axis , 2021, Human Cell.

[5]  Bo Zhang.  Guizhi Fuling pills inhibit the proliferation, migration and invasion of human cutaneous malignant melanoma cells by regulating the molecular axis of LncRNA TPT1-AS1 / miR-671-5p. , 2020, Cellular and Molecular Biology.

[6]  Fenggui Wei,et al.  MiR-216a-5p inhibits tumorigenesis in Pancreatic Cancer by targeting TPT1/mTORC1 and is mediated by LINC01133 , 2020, International journal of biological sciences.

[7]  Hao Wu,et al.  Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer , 2020, Cancer Immunology Research.

[8]  Shan Xu,et al.  miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1 , 2020, BioMed research international.

[9]  Yang Li,et al.  Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma , 2020, Molecular therapy oncolytics.

[10]  Li Zhao,et al.  Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis , 2020, Theranostics.

[11]  R. Deng,et al.  Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma , 2020, Journal for ImmunoTherapy of Cancer.

[12]  H. Fan,et al.  Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance , 2020, Oncogenesis.

[13]  Zhihong Li,et al.  Knockdown of TPT1-AS1 inhibits cell proliferation, cell cycle G1/S transition, and epithelial–mesenchymal transition in gastric cancer , 2020, Bosnian journal of basic medical sciences.

[14]  Xin Li,et al.  RETRACTED ARTICLE: The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2 , 2020, Cell cycle.

[15]  Bo Chen,et al.  The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma , 2020, Aging.

[16]  L. Du,et al.  A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer , 2020, Aging.

[17]  P. Shang,et al.  Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA , 2020, Molecular Cancer.

[18]  M. Brittan,et al.  The LINC00961 transcript and its encoded micropeptide, small regulatory polypeptide of amino acid response, regulate endothelial cell function , 2020, Cardiovascular Research.

[19]  Y. Mei,et al.  lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer , 2020, Molecular therapy. Nucleic acids.

[20]  P. Bie,et al.  LNC00673 suppresses proliferation and metastasis of pancreatic cancer via target miR-504/ HNF1A , 2020, Journal of Cancer.

[21]  Jinbao Liu,et al.  lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP , 2019, Clinical Cancer Research.

[22]  Zhen Chen,et al.  Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1 , 2019, Aging.

[23]  Yu Qin,et al.  Long Non-coding RNA JHDM1D-AS1 Interacts with DHX15 Protein to Enhance Non-Small-Cell Lung Cancer Growth and Metastasis , 2019, Molecular therapy. Nucleic acids.

[24]  Xin Wen,et al.  Long non-coding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and upregulate ITGB3. , 2019, Cancer research.

[25]  Wei Chen,et al.  Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression , 2019, Journal of experimental & clinical cancer research : CR.

[26]  Min Zhang,et al.  Long noncoding RNA FEZF1‐AS1 predicts poor prognosis and modulates pancreatic cancer cell proliferation and invasion through miR‐142/HIF‐1α and miR‐133a/EGFR upon hypoxia/normoxia , 2019, Journal of cellular physiology.

[27]  Fan Wang,et al.  LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α , 2019, Theranostics.

[28]  Yong Zhu,et al.  LncRNA TPT1‐AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression , 2019, Cancer science.

[29]  Yibin Kang,et al.  Context-dependent EMT programs in cancer metastasis , 2019, The Journal of experimental medicine.

[30]  Maolin Yan,et al.  Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8. , 2019, Cancer letters.

[31]  Dan Yang,et al.  Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling. , 2019, Cancer letters.

[32]  Rodrigo A. Mora,et al.  Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. , 2018, Cancer letters.

[33]  Lei Liu,et al.  EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer. , 2018, Cancer research.

[34]  Z. Wang,et al.  MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7 , 2018, Cell Death & Disease.

[35]  G. Wang,et al.  Long non‐coding RNA CRNDE sponges miR‐384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1 , 2017, Cell proliferation.

[36]  Iain Dickson.  Pancreatic cancer: PDAC metastases show identical known driver gene mutations , 2017, Nature Reviews Gastroenterology &Hepatology.

[37]  Huan Wang,et al.  MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3 , 2016, Cellular Physiology and Biochemistry.

[38]  Hugh Thomas.  Pancreatic cancer: CYP3A5 contributes to PDAC chemoresistance , 2016, Nature Reviews Gastroenterology and Hepatology.

[39]  A. Chinnaiyan,et al.  Long noncoding RNAs in cancer: from function to translation. , 2015, Trends in cancer.

[40]  Jie Ma,et al.  Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer , 2014, Medical Oncology.